
Wall Street Analysts And Options Market Suggest AbbVie Has Upside (NYSE:ABBV)
JHVEPhoto In early 2023, Amgen (AMGN) entered the U.S. market with a biosimilar drug to AbbVie’s (NYSE:ABBV) Humira. Humira has been the best-selling drug in the world for the past 10 years and is expected […]